Allianz Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-55,000
| Closed | -$2.25M | – | 1794 |
|
|
2024
Q2 | $2.25M | Sell |
55,000
-89,400
| -62% | -$3.66M | ﹤0.01% | 1050 |
|
|
2024
Q1 | $6.1M | Hold |
144,400
| – | – | 0.01% | 750 |
|
|
2023
Q4 | $6.12M | Buy |
+144,400
| New | +$6.12M | 0.01% | 707 |
|
|
2022
Q3 | – | Sell |
-28,220
| Closed | -$746K | – | 1714 |
|
|
2022
Q2 | $746K | Buy |
28,220
+2,360
| +9% | +$62.4K | ﹤0.01% | 1569 |
|
|
2022
Q1 | $905K | Buy |
25,860
+5,600
| +28% | +$196K | ﹤0.01% | 1589 |
|
|
2021
Q4 | $657K | Buy |
+20,260
| New | +$657K | ﹤0.01% | 1740 |
|